A Conditional Swap, Not a Universal Rule
The answer this series supports is conditional: potassium-containing lower-sodium table salt can be a useful sodium-reduction tool for some adults, but it is not a universal replacement for regular salt. The final judgment depends on three linked questions. Does the formulation actually reduce sodium while adding potassium? Does the person fall within the population for whom added potassium appears reasonably safe? And will the product replace a meaningful source of sodium in the food setting where it is used?
Those questions are more reliable than a slogan because the intervention has two sides that cannot be separated. Replacing part of sodium chloride with potassium chloride can lower sodium exposure and may lower blood pressure. The same change raises potassium exposure, which matters when potassium excretion is impaired. A product can therefore be effective on one axis and unsuitable on another. A reassuring average trial result can also have limited reach if it came from selected participants, a particular formulation or a food culture unlike the one in which the product is being considered.
The intervention is a coupled trade-off
The most useful mental model is not “regular salt versus healthy salt.” It is a coupled change in inputs. Regular table salt is predominantly sodium chloride. A lower-sodium substitute usually removes part of that sodium chloride and replaces it with potassium chloride, although some products also contain magnesium, calcium, chitosan or other ingredients. The intended effect is a lower sodium dose for a similar use of salt. The additional potassium may contribute to the blood-pressure effect, but it also creates the principal safety boundary.
That structure explains why the word “lower” can mislead. Lower sodium per unit of product does not necessarily mean lower total sodium in a person's diet. The result depends on whether the substitute is used instead of regular salt, how much is used, and how much sodium arrives from packaged food, restaurant meals and condiments. A person can make the intended chemical substitution without making a large change in total dietary sodium. The product's composition is a potential intervention; actual use determines the exposure.
The same structure explains why safety cannot be inferred from the sodium side alone. Potassium-containing substitutes change what enters the body even when they preserve the familiar flavor of salt. The evidence associates higher potassium exposure with possible blood-pressure benefit, but warns about hyperkalaemia when potassium cannot be excreted effectively. The benefit pathway and the harm pathway begin with the same reformulation. Choosing a product because it has less sodium does not answer whether its potassium content is appropriate for the intended user.
This makes efficacy and safety separate axes rather than opposite ends of one scale. Efficacy asks whether replacing regular salt changes sodium exposure, blood pressure or cardiovascular outcomes in the direction intended. Safety asks whether the added potassium can be handled by the person receiving it. A strong answer on the first axis cannot compensate for an unresolved answer on the second. Conversely, a product may be safe for a studied adult but have little effect if it does not replace the person's main sodium sources.
Adherence adds a third link. The substitute has to be accepted and used consistently. The network review found no evidence of poorer acceptance overall than regular salt, and the trials did not show a meaningful increase in withdrawals caused by the intervention. But taste perception and adherence varied by formulation and culture, and WHO identified bad taste, limited availability, lack of awareness, higher price and lack of perceived benefit as barriers. A product that is tolerated in a trial but not used at home does not deliver the expected sodium or potassium exposure.
The result is a systems problem in miniature. The mineral composition affects exposure. The person's physiology affects safety. Taste and price affect adoption. Cooking habits determine reach. Manufactured food and restaurant meals determine how much of total sodium is untouched. These factors do not make the evidence meaningless; they define the conditions under which the evidence can be meaningful.
What can be said with confidence—and what cannot
The most consistent finding is the blood-pressure effect in the adults represented by randomized trials. WHO reviewed 26 randomized controlled trials involving 34,961 adults and 92 children. Most trials focused on discretionary table salt, and all excluded people in whom increased potassium could potentially cause harm, such as people with kidney disease, impaired renal function or use of potassium-sparing medications. Compared with regular salt, lower-sodium substitutes reduced systolic blood pressure by an average of 4.76 mmHg and diastolic pressure by 2.43 mmHg.